This article is more than 5 years old. Information may no longer be current.
CIBA Vision sells epi-LASIK device to Australian company
Click Here to Manage Email Alerts
ATLANTA — CIBA Vision has sold its epi-LASIK surgical product line to Australian medical device company Norwood Abbey Ltd. The line includes the Centurion SES system and the EpiEdge epikeratome separator, CIBA Vision announced in a press release.
The devices are used in epi-LASIK, a refractive laser procedure developed by Prof. Ioannis Pallikaris.
"This is a key step in the sale of our surgical business and allows us to focus fully on our core lens and lens care businesses," said Robin Terrell, president of CIBA Vision's surgical business.
In addition to purchasing the Centurion SES EpiEdge, Norwood has also exclusively licensed the worldwide rights to Epi-LASIK from FOS Holdings. Prof. Pallikaris will act as a consultant to Norwood as a founding member of its clinical advisory board, according to the CIBA press release.
CIBA VISION previously sold several other parts of its surgical product line to the French company IOLTECH.